scholarly journals A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer

2020 ◽  
Vol 31 (5) ◽  
pp. 619-625 ◽  
Author(s):  
M.P. Kolinsky ◽  
P. Rescigno ◽  
D. Bianchini ◽  
Z. Zafeiriou ◽  
N. Mehra ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Dose Escalation ◽  
Castration Resistant Prostate Cancer ◽  
Akt Inhibitor ◽  
Dose Escalation Study ◽  
Castration Resistant

scholarly journals Phase I Dose-Escalation Study of the Novel Antiandrogen BMS-641988 in Patients with Castration-Resistant Prostate Cancer

2010 ◽  
Vol 17 (4) ◽  
pp. 880-887 ◽  
Author(s):  
Dana Rathkopf ◽  
Glenn Liu ◽  
Michael A. Carducci ◽  
Mario A. Eisenberger ◽  
Aseem Anand ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Dose Escalation ◽  
The Novel ◽  
Castration Resistant Prostate Cancer ◽  
Dose Escalation Study ◽  
Castration Resistant

Phase I dose-escalation study of AGS-1C4D4, an anti-PSCA human antibody in castration-resistant prostate cancer (CRPC).

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 4669-4669
Author(s):  
M. A. Carducci ◽  
M. A. Eisenberger ◽  
S. R. Denmeade ◽  
S. F. Slovin ◽  
A. Jakobovits ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Dose Escalation ◽  
Human Antibody ◽  
Castration Resistant Prostate Cancer ◽  
Dose Escalation Study ◽  
Castration Resistant
Sign in / Sign up

Export Citation Format

Share Document